HighLight Capital (HLC) is an investment management firm with a mission to promote technology innovations based on deep scientific and industrial insights. HLC focuses on enabling high growth sectors such as healthcare, biotech and consumer, and strives to create long-term value. HLC currently manages over US$2.0 billion, with offices in Shanghai, Beijing and Shenzhen.

As of today, HLC has invested in over 90 leading companies. More than 20 of them have been listed on the Shanghai Stock Exchange, Hong Kong Stock Exchange and Nasdaq, including Mindray, Wuxi Apptec, Tigermed, Pharmaron, United Imaging, Brightgene, Sansure, Kintor, Genetron, Zentalis, Singular, Smoore, Nayuki and more.